ΠΠΊΡΠΈΠ²Π°ΡΠΈΡ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ² Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ ΠΈ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π½Π° Π½Π΅Π΅ Π°Π½ΡΠΈΠ³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ²Π½ΡΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΡΡΠ΅Π΄ΡΡΠ²
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΡ ΠΈ Π°ΠΏΡΠΎΠ±Π°ΡΠΈΡ ΡΠ°Π±ΠΎΡΡ ΠΠΎ ΡΠ΅ΠΌΠ΅ Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ ΠΎΠΏΡΠ±Π»ΠΈΠΊΠΎΠ²Π°Π½ΠΎ 7 Π½Π°ΡΡΠ½ΡΡ ΡΠ°Π±ΠΎΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠ°Π±ΠΎΡΡ Π΄ΠΎΠ»ΠΎΠΆΠ΅Π½Ρ Π½Π° Π½Π°ΡΡΠ½ΠΎ-ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΡΡ ΠΌΠΎΠ»ΠΎΠ΄ΡΡ ΡΡΡΠ½ΡΡ (ΠΠ°Π·Π°Π½Ρ, 2001, 2002, 2003), Π½Π° Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΌ Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΌ ΠΊΠΎΠ½Π³ΡΠ΅ΡΡΠ΅ ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΎΠ² (ΠΠΎΡΠΊΠ²Π°, 2003), Π½Π° ΠΠΎΠ½Π³ΡΠ΅ΡΡΠ΅ Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΎΠ² ΡΡΡΠ°Π½ Π‘ΠΠ (Π‘Π°Π½ΠΊΡ-ΠΠ΅ΡΠ΅ΡΠ±ΡΡΠ³, 2003). ΠΠ±ΡΡΠΌ ΠΈ ΡΡΡΡΠΊΡΡΡΠ° Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ. ΠΠ½ΡΠΈΠ³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ²Π½ΡΠ΅ ΡΡΠ΅Π΄ΡΡΠ²Π° ΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΠΠ‘ΠΠ Π‘ΠΠΠ ΠΠ©ΠΠΠΠ
- ΠΠ»Π°Π²Π° 1. ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- 1. 1. ΠΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎ Π²Π»ΠΈΡΠ½ΠΈΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΡΡΠ΅Π΄ΡΡΠ² Π½Π° ΡΠ°ΡΡΠΎΡΡ ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ ΠΊΠ°ΡΠ°ΡΡΡΠΎΡ
- 1. 2. Π’ΡΠΎΠΌΠ±ΠΎΡΠΈΡΡ ΠΈ ΠΈΡ ΡΡΠ°ΡΡΠΈΠ΅ Π² ΠΏΡΠΎΡΠ΅ΡΡΠ°Ρ Π²Π½ΡΡΡΠΈΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠ³ΠΎ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ ΡΡΠΎΠΌΠ±Π°
- 1. 3. ΠΠΊΡΠΈΠ²Π°ΡΠΈΡ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ² ΠΈ Π -ΡΠ΅Π»Π΅ΠΊΡΠΈΠ½ ΠΊΠ°ΠΊ ΠΌΠ°ΡΠΊΡΡ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ
- 1. 4. Π£ΡΠ»ΠΎΠ²ΠΈΡ, Π²Π»ΠΈΡΡΡΠΈΠ΅ Π½Π° Π°ΠΊΡΠΈΠ²Π°ΡΠΈΡ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ²
- 1. 5. ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΡΡΠ΅ΠΊΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΠΎΠΉ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠ°ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ
- 1. 6. ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΠΈΡΠΎΡΠ»ΠΎΡΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π -ΡΠ΅Π»Π΅ΠΊΡΠΈΠ½Π°
- 1. 7. ΠΠ»ΠΈΡΠ½ΠΈΠ΅ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΡΡΠ΅Π΄ΡΡΠ² Π½Π° ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠ°ΡΠ½ΡΠ΅ ΡΡΠ½ΠΊΡΠΈΠΈ
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ°Π»ΡΠ²ΠΈΡ Π.Π‘. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΡ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΠΉ / Π.Π‘. ΠΠ°Π»Ρ-Π²ΠΈΡ. — ΠΠ°Π·Π°Π½Ρ: ΠΠ£Π «ΠΠΈΠΊ ΠΠ΄Π΅Π»-ΠΡΠ΅ΡΡ», 2000. — 169 Ρ.
- ΠΠ°Π»ΡΠ²ΠΈΡ Π.Π‘. ΠΡΠ΄Π΅Π»ΡΠ½ΡΠ΅ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΠ΅ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΠΈ. / Π. Π‘. ΠΠ°Π»ΡΠ²ΠΈΡ. — ΠΠ°Π·Π°Π½Ρ: ΠΠ£Π «ΠΠΈΠΊ ΠΠ΄Π΅Π»-ΠΡΠ΅ΡΡ», 2002. — 116 Ρ.
- ΠΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΡΠΉ Π΄ΠΎΠΊΠ»Π°Π΄ ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅-ΡΠ°Π΄ΠΈΠΈ Π² 2000 Π³ΠΎΠ΄Ρ // ΠΠ΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΠ΅ Π ΠΎΡ. Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ. — 2002. — № 5. — Π‘. 3−19.
- ΠΠ΅ΠΌΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π΅ΠΆΠ΅Π³ΠΎΠ΄Π½ΠΈΠΊ Π ΠΎΡΡΠΈΠΈ, ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ±ΠΎΡΠ½ΠΈΠΊ. ΠΠΎΡΠΊΠΎΠΌΡΡΠ°Ρ Π ΠΎΡΡΠΈΠΈ. — Π., 1997. — Π‘. 580.
- ΠΠΎΠ±Π°Π»Π°Π²Π° Π.Π. ΠΡΠΎΠ³ΡΠ΅ΡΡ Π²ΠΎ Π²ΡΠΎΡΠΈΡΠ½ΠΎΠΉ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ ΠΈΠ½ΡΡΠ»ΡΡΠΎΠ² (ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ PROGRESS) / Π. Π. ΠΠΎΠ±Π°Π»Π°Π²Π°, B.C. ΠΠΎΠΈΡΠ΅Π΅Π² // ΠΠ»ΠΈΠ½. ΡΠ°ΡΠΌ. ΡΠ΅Ρ. — 2001. — № 10 (4). — Π‘. 39−42.
- ΠΠΎΠΈΡΠ΅Π΅Π² B.C. ΠΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ° Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠΈ Π² ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ ΠΈΠ»ΠΈ Π² Π³ΡΡΠΏΠΏΠ΅ ΡΠΈΡΠΊΠ° / B.C. ΠΠΎΠΈΡΠ΅Π΅Π² // ΠΠ». ΡΠ°ΡΠΌ. ΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΡ. — 1998. — № 13. — Π‘. 512.
- ΠΠ³Π°Π½ΠΎΠ² Π .Π. ΠΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠΈ Π² Π ΠΎΡΡΠΈΠΈ ΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ / Π . Π. ΠΠ³Π°Π½ΠΎΠ² // Π’Π΅Ρ. Π°ΡΡ ΠΈΠ². — 1997. — Π’.54. — № 4. — Π‘.13−15.
- ΠΠ³Π°Π½ΠΎΠ² Π .Π. Π‘Π΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΡΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π² Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ Π²ΠΎ Π²ΡΠΎΡΠΎΠΉ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ΅ XX ΡΡΠΎΠ»Π΅ΡΠΈΡ: ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΡ, Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠ΅ ΠΏΡΠΈΡΠΈΠ½Ρ, ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ / Π . Π. ΠΠ³Π°Π½ΠΎΠ², Π. Π―. ΠΠ°ΡΠ»Π΅Π½Π½ΠΈΠΊΠΎΠ²Π° // ΠΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ. — 2000. — № 6. — Π‘. 4−8.
- ΠΡΠ΅ΠΏΠΊΠΎΠ²Π° Π.Π. Π£ΡΡΠ΅Π½Π½ΠΈΠΉ ΠΏΠΎΠ΄ΡΡΠΌ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π΄Π°Π²Π»Π΅Π½ΠΈΡ (ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΡΡΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ) ΠΈ Π°Π³ΡΠ΅Π³Π°ΡΠΈΡ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ² Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ / Π. Π. ΠΡΠ΅ΠΏΠΊΠΎΠ²Π°, Π. Π. ΠΠ°Π·Π°ΡΠ΅Π²Π°, Π. Π. Π€ΠΈΠ»Π°ΡΠΎΠ²Π° // Π’Π΅Ρ. Π°ΡΡ ΠΈΠ². — 2000. — № 4. — Π‘. 47−51.
- Π ΠΌΠ΅ΡΠ°Ρ ΠΏΠΎ ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΡ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π±ΠΎΠ»ΡΠ½ΡΠΌ Ρ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΠ΅ΠΉ Π² Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΡΠ΅Π΄Π΅ΡΠ°ΡΠΈΠΈ: ΠΡΠΈΠΊΠ°Π· ΠΠΈΠ½Π·Π΄ΡΠ°Π²Π°
- Π ΠΎΡΡΠΈΠΈ ΠΎΡ 24.01.03 № 4 // ΠΠ΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΠ΅. — 2003. — № 6. — Π‘. 76−115.
- ΠΡΡΠ΅Π²ΡΠΊΠΈΠΉ Π.Π¨. Π’ΡΠΎΠΌΠ±ΠΎΡΠΈΡΡ (ΡΠΎΡΡΠ°Π², ΡΡΠ½ΠΊΡΠΈΡ, Π±ΠΈΠΎΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅) / Π. Π¨. ΠΡΡΠ΅Π²ΡΠΊΠΈΠΉ, C.JI. ΠΠ°Π»ΡΠ½, Π. Π. ΠΠ΅ΠΌΠ΅Π½ΡΡΠ΅Π²Π°. — Π’ΡΠΌΠ΅Π½Ρ, 1996. — 144 Ρ.
- Π€Π΅Π΄Π΅ΡΠ°Π»ΡΠ½Π°Ρ Π¦Π΅Π»Π΅Π²Π°Ρ ΠΡΠΎΠ³ΡΠ°ΠΌΠΌΠ° «ΠΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ° ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΠΈ Π² Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ». — Π., 2001.
- Π€Π΅ΡΠΈΡΠ΅Π²Π° Π.Π‘. ΠΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡ — ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ° ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ / Π. Π‘. Π€Π΅ΡΠΈΡΠ΅Π²Π°, Π. Π. ΠΠ»ΠΈΠΏΠ΅Π»Ρ // Π‘Π΅ΡΡΡΠΈΠ½ΡΠΊΠΎΠ΅ Π΄Π΅Π»ΠΎ. — 2003. — № 3 (45) — Π‘. 10−11.
- Abela G.S. Laser-light scattering, a new method for continuous monitoring of platelet activation in circulating fluid / G.S. Abela, R. Huang, H. Ma // J. Lab. Clin. Med. — 2003. — Vol. 141(1). — P. 50−57.
- Alvarez-Guerra M. The hemostatic agent ethamsylate enhances P-selectin membrane expression in human platelets and cultured endothelial cells / M. Alvarez-Guerra, M. R Hernandez, G. Escolar // Thromb Res. — 2002. —Vol. 107(6). — P. 329−335.
- Andrews N.P. Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study / N.P. Andrews, H.R. Gralnick, P. Merryman // J. Am. Coll. Cardiol. — 1996. — Vol. 28(7). — P. 1789−1795.
- Andrews R.K. Molecular mechanisms of platelet adhesion and activation / R.K. Andrews, J.A. Lopez, M.C. Berndt // Int. J. Biochem. Cell Biol. — 1997. — Vol. 29(1). —P. 91−105.
- Andrioli G. Study of platelet adhesion in patients with uncomplicated hypertension/ G. Andrioli, R. Ortolani, L. Fontana // J. Hypertens. — 1996.— Vol. 14(10). —P. 1215−1221.
- Ardlie N.G. Influence of catecholamines on nucleotide-induced platelet aggregation / N.G. Ardlie, G. Glew, C.J. Schwartz // Nature. — 1966. — Vol. 212. — P. 415−417.
- Becker B.F. Endothelial function and hemostasis / B.F. Becker, B. Heindl,
- C. Kupatt // Z. Kardiol. — 2000. — Vol. 89(3). — P. 160−167.
- Becker R.C. Dynamic nature of thrombin generation, fibrin formation, and platelet activation inunstable angina and non-Q-wave myocardial infarction / R.C. Becker, E.G. Bovill, J.M. Corrao // J. Thromb. Thrombolysis — 1995.— Vol. 2(1). — P. 57−64.
- Berger G. P-Selectin and Platelet Clearance / G. Berger, D.W. Hartwell,
- D.D. Wagner // Blood. — 1998. — Vol. 92(11). — P. 4446−4452.
- Berman C.L. A platelet alpha-granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein / C.L. Berman,
- E.L. Yeo, J.D. Wencel-Drake // J. Clin. Invest. — 1986. — Vol. 78 (130).
- Blann A.D. Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers / A.D. Blann, G.Y.H. Lip, D.G. Beevers // Thromb. Haemost. — 1997. — Vol. 77. — P. 1077.
- Blann A.D. Pharmacological Modulation of Platelet Function in Hypertension / A.D. Blann, S. Nadar, G.Y.H. Lip // Hypertension. — 2003. — Vol. 42(1) — P. 1−7.
- Blann A.D. Soluble P-selectin in peripheral vascular disease: Relationship to the location and extent of atherosclerotic disease and its risk factors / A.D. Blann, M. Seigneur, M.R. Boisseau // Blood Coagul. Fibrinolysis. — 1996. — Vol. 7. — P. 789.
- Bonfanti R PADGEM (GMP-140) is a component of Weibel-Palade bodies of human endothelial cells / R Bonfanti, B.C. Furie, B. Furie // Blood. — 1989. — Vol. 73. —P. 1109.
- Bosio P.M. Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia / P.M. Bosio, S. Cannon, P.J. McKenna// Π JOG. — 2001. —Vol. 108(7). —P. 709−715.
- Bray P.F. Pkatelt glycoprotein polymorphisms as risk factor for thrombosis / P.F. Bray // Curr. Opin. Hematol. — 2000. — Vol. 7(5). — P. 284−289.
- Broadley AJ. Supine rest reduces platelet activation and aggregation / A.J. Broadley, P. Gapper, M. Schmitt // Platelets. — 2003. — Vol. 14(1). — P. 3−7.
- Brooks D.P. Pharmacology of eprosartan, an angoitensin II receptor agonist: exploring hypothesis from clinical data / D.P. Brooks, E.H. Ohlstein, R.R. Ruffolo // Am. Heart. — 1999.—Vol. 138. —P. 247−251.
- Burger P.C. Platelet P-selectin facilitates atherosclerotic lesion development / P.C. Burger, D.D. Wagner // Blood. — 2003. — Vobo 101(7). — P. 2661−2666.
- Cattaneo M. Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients / M. Cattaneo, R.L. Kinlough-Rathbone, A. Lecchi // Blood. — 1987. — Vol. 70. — P. 221−226.
- Chong B.H. Plasma P-selectin is increased in thrombotic comsumptive platelet disorders / B.H. Chong, B. Murray, M.C. Berndt // Blood. — 1994. — Vol. 83. — P. 1535.
- Controversies in the management of heart failure // Ed. Coats A. — Churchill Livingstone, 1997. —179 p.
- Dai H. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty / H. Dai, J. Chen, Q. Tao // Postgrad. Med. J. — 2003. — Vol. 79(935). — P. 522−526.
- Davenpeck K.L. Activation of human leukocytes reduce surface P-selectin glycoprotein ligand-1 (PSGL-1, CD 162) and adhesion to P-selectin in vitro / K.L. Davenpeck, M.E. Brummet, S.A. Hudson // J. Immunol. — 2000. — Vol. 165(5).—P. 2764−2772.
- De Caterina R. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis / De Caterina R., Basta G., Lazzerini G. // Arterioscl. Thromb. Vase. Biol. — 1997. — Vol. 17. — P. 2646−2654.
- De Leeuw F.E. Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease / F.E. de Leeuw, M. de Kleine, C.J. Frijns // Ann. N. Y. Acad. Sci. — 2002. — Vol. 977. — P. 306−314.
- Dockrell M.E. Platelet aggregation in young men with contrasting predisposition to high blood pressure / M.E. Dockrell, B.R. Walker, J.P. Noon // Am J Hypertens. — 1999. —Vol. 12(2 Pt 1). — P. 115−119.
- Dunlop L.C. Characterization of GMP-140 (P-selectin) as a circulating plasma protein / L.C. Dunlop, M.P. Skinner, L.J. Bendall // J. Exp. Med. — 1992. — Vol. 175. —P. 1147−1150.
- Einecke D. PROGRESS Study examines transient cerebral ischemia and stroke patients / D. Einecke // Fortschr Med. — 2001. — Vol. 143(26−27). — P. 4−5.
- El-Sayed M.S. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation / M.S. El-Sayed // Sports Med. — 1996. — Vol. 22. — P. 282−298.
- Elstad M.R. The interaction of leukocytes with platelets in blood coagulation / M.R. Elstad, T.M. Mclntyre, S.M.Prescott // Curr. Opin. Hematol. — 1995.— Vol. 2. —P. 47.
- Facer C.A. Elevated plasma level of P-selectin (GMP-140/CD62) in patients with Plasmodium falciparum malaria / C.A. Facer, A. Theodoridou // Microbiol. Immunol. — 1994. — Vol. 38. — P. 727.
- Freedman J.E. Nitric oxide released from activated platelets inhibits platelet recruitment / J.E. Freedman, J. Loscalzo, M.R. Barnard // J. Clin. Invest. — 1997. — Vol. 100(2). —P. 350−356.
- Frenette P. S. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin / P. S. Frenette, R.C. Johnson, R.O. Hynes // Proc. Natl. Acad. USA. — 1995. — Vol. 92. — P. 7450.
- Frijns C.J. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis / C.J. Frijns, LJ. Kappelle, J. van Gijn // Stroke. — 1997. — Vol. 28. — P. 2214.
- Gamble J. R Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140 / J. R Gamble, M.P. Skinner, M.C. Berndt// Science. — 1990. — Vol. 249. — P. 414−417.
- Gasperetti C.M. Platelet activation during coronary angioplasty in humans / C.M. Gasperetti, S.L. Gonias, L.W. Gimple // Circulation. — 1993. — Vol. 88. — P. 2728−2734.
- Goldberger A. Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form / A. Goldberger, K.A. Middleton, J.A. Oliver//J. biol. Chem.— 1994. —Vol. 269. —P. 17 183−17 191.
- Guarnieri C. Spontaneous superoxide generation by polymorphonuclear leukocytes isolated from patients with stable angina after physical exercise / C. Guarnieri, G. Melandri, I. Caldarera // Int. J. Cardiol. — 1992. — Vol. 37. — P. 301−307.
- Gupta R.K. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor / R.K. Gupta, S.E. Kjeldsen, E. Motley//J. Cardiovasc. Pharmacol. — 1991. — Vol. 17(1). — P. 13−19.
- Hagberg I.A. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies / I.A. Hagberg, T. Lyberg // Platelets. — 2000. — Vol. 11(3). —P. 137−150.
- Hagberg I.A. Platelet activation in flowing blood passing growing arterial thrombi / I.A. Hagberg, H.E. Roald, T. Lyberg // Arterioscler. Thromb. Vase. Biol. — 1997. —Vol. 17(7).—P. 1331−1336.
- Halim A. Plasma P-selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: Their significances / A. Halim, N. Kanayama, E. El Ma-radny // Am. J. Obstet. Gynecol. — 1996. — Vol. 174. — P. 72.
- Hashimoto H. Circulating adhesion molecules are correlated with ultrasonic assessment of carotid plaques / H. Hashimoto, K. Kitagawa, K. Kuwabara // Clin. Sci. (Lond). — 2003. — Vol. 104(5). — P. 521−527.
- Hawiger J. Mechanisms involved in platelet vessel wall interaction / J. Hawiger // Thromb. Haemost. — 1995. — Vol. 74. — P. 369−372.
- Hezard N. Platelet activation in cardiology: methods, indications and therapeutic perspectives / N. Hezard, D. Metz, G. Simon // J. Mai. Vase. — 1999. — Vol. 24(4). —P. 288−293.
- Hjemdahl P. Effects of stress and beta-blockade on platelet function / P. Hjemdahl, P.T. Larsson, N.H. Wallen // Circulation. — 1991. — Vol. 84(suppl VI). — P. 44−61.
- Hjemdahl P. Calcium antagonist treatment, sympathetic activity and platelet function / P. Hjemdahl, N.H. Wallen // Eur. Heart J. — 1997. — Vol. 18(suppl A). — P. 36−50.
- Hlubocka Z. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors / Z. Hlubocka,
- V. Umnerova, S. Heller//J. Hum. Hypertens. — 2002. Vol. 16(8). — P. 557−362.
- Hollander J.E. Risk stratification of emergency department patients with acute coronary syndromes using P-selectin / J.E. Hollander, M.R. Mutreja, M.R. Dalesandro // J. Am. Coll. Cardiol. — 1999. — Vol. 34(1). — P. 95−105.
- Hsu-Lin S.C. A platelet membrane protein expressed during platelet activation and secretion / S. Hsu-Lin, C.L.Berman, B.C.Furie // J. Biol. Chem. — 1984. — Vol. 259(9121).
- Huo Y. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E / Y. Huo, A. Schober, S.B. Forlow // Nat. Med. — 2003. — Vol. 9(1). — P. 61−67.
- Hyson D.A. Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men / D.A. Hyson, T.G. Paglieroni, T. Wun // Clin. Appl. Thromb. Hemost. — 2002. —1. Vol. 8(2).—P. 147−155.
- Dceda H. Soluble form of P-selectin in patients with acute myocardial infarction / H. Ikeda, H. Nakayama, T. Oda // Coron. Artery Dis. — 1994. — Vol. 5. — P. 515−518.
- Ikeda H. Adhesive interaction between P-selectin and sialyl Lewis (x) plays an important role in recurrent coronary arterial thrombosis in dogs / H. Ikeda, T. Ueyama, T. Murohara // Arterioscler. Thromb. Vase. Biol. — 1999. — Vol. 19. —P. 1083−1090.
- Inoue T. Detection of platelets activated during acetylcholine-induced coronary vasospasm / T. Inoue, T. Fujito, K. Hoshi // Thromb. Haemost. — 1998. — Vol. 79(5). —P. 1004−1007.
- Jacoby R.C. Platelet activation and function after trauma / R.C. Jacoby, J.T. Owings, J. Holmes // J. Trauma. — 2001. — Vol. 51(4). — P. 639−647.
- Jayachandran M. Effects of ovariectomy on aggregation, secretion, and metallopro-teinases in porcine platelets / M. Jayachandran, W.G. Owen, V.M. Miller // Am. J. Physiol. Heart Circ. Physiol. — 2003. — Vol. 284(5). — P. 679−685
- Jilma B. Elevated circulating P-selectin in insulin dependent diabetes mellitus/ B. Jilma, P. Fasching, C. Ruthner // Thromb. Haemost. — 1996. — Vol. 76. — P. 328.
- Jilma B. Effects of estradiol on circulating P-selectin / B. Jilma, J. Hildebrandt, S. Kapiotis // J. Clin. Endocrinol. Metab. — 1996. — Vol. 81. — P. 2350.
- Jimenez A.M. Inhibition of platelet activation in stroke-prone spontaneously hypertensive rats: comparison of losartan, candesartan, and valsartan / A.M. Jimenez, M. Monton, R Garcia // J. Cardiovasc. Pharmacol. — 2001.— Vol. 37(4). — P. 406−412.
- Kamath S. Platelet activation: assessment and quantification / S. Kamath, A.D. Blann, G.Y.H. Lip //Eur. Heart. J. — 2001. — Vol. 22. — P. 1561−1571.
- Katayama M. A monoclonal antibody-based enzyme immunoassay for human GMP-140/P-selectin / M. Katayama, M. Handa, H. Ambo // J. Immunol. Methods.—1992.—Vol. 153. —P. 41.
- Kinlough-Rathbone R.L. Factors influencing the deaggregation of chymotrypsin-treated human platelets aggregated by fibrinogen / R.L. Kinlough-Rathbone, J.F. Mustard, M.A. Packham // Thromb. Haemost. — 1983. — Vol. 49. — P. 196 198.
- Knight C.J. Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina / C.J.Knight, M. Panesar, D.J.Wilson // Circulation. — 1997. — Vol. 95(1). — P. 125−132.
- Kohmura C. Detection of activated platelets by flow cytometry / C. Kohmura, Y. Hayashi, H. Ikeda // Rinsho Byori — 1999. — Vol. 47(5). — P. 447−452.
- Koyama H. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans / H. Koyama, T. Maeno, S. Fukumoto // Circulation. 2003. — Vol. 108(5). — P. 524−529.
- Kozuka Π. Endothelial markers and adhesion molecules in acute ischemic stroke-sequential change and differences in stroke subtype / K. Kozuka, T. Kohriyama, E. Nomura // Atherosclerosis. — 2002. — Vol. 161(1). — P. 161−168.
- Langford E.J. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors / E.J. Langford, R.J. Wainwright, J.F. Martin // Arterioscler. Thromb. Vase. Biol. — 1996. — Vol. 16(1). — P. 51−55.
- Larsen E. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes / E. Larsen, A. Celi, G.E. Gilbert // Cell. — 1989. — Vol. 59. — P. 305−312.
- Larsson P.T. Platelet activation during angiotensin II infusion in healthy volunteers / P.T. Larsson, J.H. Schwieler, N.H. Wallen // Blood Coagul. Fibrinolysis. — 2000. —Vol. 11(1).—P. 61−69.
- Larsson P.T. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin / P.T. Larsson P.T., N.H. Wallen, P. Hjemdahl // Circulation.—1994.—Vol. 89. —P. 1951−1957.
- Li N. Evidence for prothrombotic effects of exercise and limited protection by aspirin / N. Li, N.H. Wallen, P. Hjemdahl // Circulation. — 1999. — Vol. 100(13). — P. 1374−1379.
- Li Y.N. Study on endothelial dysfunction and platelet activation in elderly hypertensive patients complicated with cerebral infarction / Y.N. Li, H. Yuan, M.X. Zhang // Hunan Yi Ke Da Xue Xue Bao. — 2001. — Vol. 26(2). — P. 143 145.
- Lip G.Y. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report / G.Y. Lip, A.D. Blann, J. Zarifis // J. Hypertens. — 1995. — Vol. 13(12 Pt 2).—1. P. 1674−1678.
- Malinin A.I. Paradoxical activation of major platelet receptors in the methadone-maintained patients after single pill of aspirin / A.I. Malinin, K.P. Callahan, V.L. Serebruany // Thromb. Res. — 2001. — Vol. 104(4). — P. 297−299.
- Marcus A.J. Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in-vitro / A.J. Marcus, M.J. Broekman, L.B. Safier // Bio-chem. Biophys. Res. Commun. — 1982. — Vol. 109. — P. 130.
- Mayadas T.N. Leukocyte rolling and extravasation are severely compromised in P-selectin deficient mice / T.N. Mayadas, R.C. Johnson, H. Rayburn // Cell. — 1993. —Vol. 74. —P. 541.
- McEver R.P. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies / R.P. McEver, J.H. Beckstead, K.L. Moore // J. Clin. Invest. — 1986. — Vol. 84. — P. 92−99.
- McEver R.P. Leukocyte trafficking mediated by selectin-carbohydrate interactions/ R.P. McEver, K.L. Moore, RD. Cummings // J. Biol. Chem. — 1995. — Vol. 270. —P. 110−125.
- Merten M., Thiagarajan P. P-selectin expression on platelets determines size and stability of platelet aggregates // Circulation. — 2000. — Vol. 102(16). — P. 19 311 936.
- Michelson A.D. Evaluation of platelet function by flow cytometry / A.D. Michelson, M.R. Barnard, L.A. Krueger // Methods. — 2000. — Vol. 21(3). — P. 259−270.
- Miller M.A. Ethnic differences in circulating soluble adhesion molecules: the Wandsworth Heart and Stroke Study / M.A. Miller, G.A. Sagnella, S.M. Kerry // Clin. Sci. (Lond). —2003. — Vol. 104(6). —P. 591−598.
- Moroff G. Effect on platelet properties of exposure to temperatures below 20-degrees-C for short periods during storage at 20 to 24-degrees-C / G. Moroff, S. Holme, V.M. George // Transfusion. — 1994. — Vol. 34. — P. 317.
- Moshfegh K. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy / K. Moshfegh, M. Redondo, F. Julmy // J. Am. Coll. Cardiol. — 2000. — Vol. 36(3). —P. 699−705.
- Murakami T. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease / T. Murakami, Y. Komiyama, M. Masuda // Eur. J. Clin. Invest. — 1996. — Vol. 26(11). — P. 996−1003.
- Nomura S. Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines / S. Nomura, A. Imamura, M. Okuno // Thromb. Res. — 2000. — Vol. 98(4). — P. 257−68.
- Nurden A.T. Markers of platelet activation in coronary heart disease patients /
- Π.Π’.Nurden, L. Macchi, C. Bihour // Eur. J. Clin. Invest. — 1994. — Vol.24, Suppl 1. —P. 42−45.
- Nylander S. Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action / S. Nylander, C. Mattsson // Blood Coagul. Fibrinolysis. — 2003. — Vol. 14(2). — P. 159−167.
- O’Connor C.M. Usefulness of soluble and surface bound P-selectin in detecting hightened platelet activity in patients with congestive heart failure / C.M. O’Connor, P.A. Gurbel, V.L. Serebruany // Am. J. Cardiol. — 1999. — Vol. 83. —P. 1345−1349.
- Okrucka A. Effects on the angiotensin-converting enzyme (ACE) inhibitor perin-dopril on endotelial and platelet functions in essential hypertension / A. Okrucka, J. Pechan, H. Kratochvilova // Platelets. — 1998. — Vol. 9. — P. 63−67.
- Ouvina S.M. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients / S.M. Ouvina, R.D. La Greca, N.L. Zanaro // Thromb. Res. — 2001. — Vol. 102(2). — P. 107−114.
- Pernerstorfer T. Low-dose aspirin does not lower in vivo platelet activation in healthy smokers / T. Pernerstorfer, P. Stohlawetz, G. Stummvoll // Br. J. Haematol. — 1998. —Vol. 102(5). — P. 1229−1231.
- Pigott R Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the su-pernatants of cytokine activated cultured endothelial cells / R. Pigott, L.P. Dillon, I.H. Hemingway // Boichem. Biophys. Res. Commun. — 1992.— Vol. 187. — P. 584−589.
- Piqueras L. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT (1) and AT (2) receptor-mediated P-selectin upregulation / L. Piqueras, P. Kubes, A. Alvarez // Circulation. — 2000. — Vol. 102(17). — P. 2118−2123.
- PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attac//Lancet. — 2001. — Vol. 29(358). — P. 1033−1041.
- Prorock A.J. Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase / A.J. Prorock, A. Hafezi- Moghadam, V.E. Laubach // Am. J. Physiol. Heart Circ. Physiol. — 2003. —Vol. 284(1). — P. 133−140.
- Radomski M.W., Palmer R.M.J., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium // Lancet. — 1987. — Vol. II. — P. 1057−1058.
- Rauch U. Platelet activation in diabetic cardiovascular autonomic neuropathy/ U. Rauch, D. Ziegler, R. Piolot // Diabet. Med. — 1999. — Vol. 16(10). — P. 848−852.
- Reimers H.J. Survival of washed rabbit platelets in vivo / H.J. Reimers, M. R Buchanan, J.F. Mustard // Proc. Soc. Exp. Biol. Med. — 1973. — Vol. 142. —P. 1222.
- Reimers H.J. In vivo and in vitro functions of thrombin-treated platelets / H.J. Reimers, R.L. Kinlough-Rathbone, J.P. Cazenave // Thromb. Haemost. — 1976. —Vol.35. —P. 151.
- Reimers H.J. Effect of repeated treatment of rabbit platelets with low concentration of thrombin on their function, metabolism and survival / H.J. Reimers, M.A. Packham, RL. Kinlough-Rathbone // Br. J. Haematol. — 1973. — Vol. 25. —P. 675.
- Rein D. Cocoa and wine polyphenols modulate platelet activation and function / D. Rein, T.G. Paglieroni, D.A. Pearson // J. Nutr. — 2000. — Vol. 130. — P. 2120−2126.
- Ridker P.M. Soluble P-selectin and the risk of future cardiovascular events / P.M. Ridker, J.E.Buring, N. Rifai // Circulation. — 2001. Vol. 103(4). — P. 491−495.
- Rinder H.M. Platelet function testing by flow cytometry / H.M. Rinder // Clin. Lab. Sci. — 1998. — Vol. 11(6). — P. 365−372.
- Robless P. Vascular surgical society of great britain and ireland: platelet function during carotid endarterectomy and the antiplatelet effect of dextran 40 / P. Robless,
- D. Okonko, T. Tegos // Br. J. Surg. — 1999. — Vol. 86(5). — P. 709.
- Rodgers A. Blood pressure lowering for the secondary prevention of myocardial infarction and stroke / A. Rodgers, D. Neal, S. McMahon // Hypertension. — 1997. — Vol. 29(2). —P. 537−538.
- Rothlein R. A form of circulating ICAM-1 in human serum / R. Rothlein,
- E.A. Mainolfi, M. Czajakowski // J. Immunol. — 1991. — Vol. 147 — P. 3788−3793.
- Rupprecht H.J. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation / H.J. Rupprecht, H. Darius, U. Borkowski // Circulation. — 1998. —Vol. 97(11). —P. 1046−1052.
- Sanguigni V. Effect of amlodipine on exercise-induced platelet activation in patients affected by chronic stable angina / V. Sanguigni, M. Gallu, L. Sciarra // Clin. Cardiol. — 1999. — Vol. 22. — P. 575−580.
- Sechi L.A. Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients / L.A. Sechi, C. Catena, D. Casaccio // J. Hypertens. — 2000. — Vol. 18(6). —P. 709−716.
- Sechi L.A. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension / L.A. Sechi, L. Zingaro, C. Catena // Hypertension. — 2000. — Vol. 36(6). — P. 978−985.
- Shattil S.J. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry / S.J. Shattil, M. Cunningham, J.A. Hoxie // Blood. — 1987. — Vol. 70. — P. 307−315.
- Siminiak T. The release of soluble adhesion molecules ICAM-1 and E-selectin after acute myocardial infarction and following coronary angioplasty / T. Siminiak,
- J.F. Dye, R.M. Egdell // Int. J. Cardiol. — 1997. — Vol. 61. — P. 113−118.
- Simoncini T. Interaction of oestrogen receptor with the regulatory subunit of phos-phatidylinositol-3-ΠΠ kinase / T. Simoncini, A. Hafezi-Moghadam, D.P. Brazil // Nature. — 2000. — Vol. 28−407(6803). — P. 538−541.
- Sleiffenbaum B. Soluble L-selectin is present in human plasma at high levels and retains functional activity / B. Sleiffenbaum, O. Spertini, T.F. Tedder //J. Cell. Biol. 1992. —Vol. 119. —P. 229−238.
- Staessen J.A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension / J.A. Staessen, R Fagard, L. Thijs // Lancet. — 1997. — Vol. 13(350). — P. 757−764.
- Subramaniam M. Defects in hemostasis in P-selectin-deficient mice / M. Subramaniam, P. S. Frenette, S. Saffaripour // Blood. — 1996. — Vol. 87.— P. 1238.
- Subramaniam M. Divergent fates of P-and E-selectin after their expression on the plasma membrane / M. Subramaniam, J.A. Koedam, D.D. Wagner // Mol. Biol. Cel. — 1993. — Vol. 14. — P. 791.
- Tailor A. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules / A. Tailor, D.N. Granger // Arterioscler. Thromb. Vase. Biol. — 2003. — Vol. 23(4). — P. 675−580.
- Taylor M.L. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils / M.L. Taylor, M.K. Ilton, N.L. Misso // Br. J. Clin. Pharmacol. — 1998. — Vol. 46(2). — P. 139−145.
- The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure // Lancet. — 1993. — Vol. 2(3 428 875). —P. 821−828.
- Thiagarajan P. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles / P. Thiagarajan, J.F. Tait // J. Biol. Chem. — 1991. — Vol. 266(36). — P. 24 302−24 307.
- Thijs A. Effects of hormone replacement therapy on blood platelets / A. Thijs, W.M. van Baal, MJ. van der Mooren // Eur. J. Clin. Invest. — 2002. — Vol. 32(8). —P. 613−618.
- Tregouet D.A. Specific haplotypes of the P-selectin gene are associated with myocardial infarction / D.A. Tregouet, S. Barbaux, S. Escolano // Hum. Mol. Genet. — 2002. —Vol. 15−11(17). — P. 2015−2023.
- Undar L. Flow cytometric analysis of circadian changes in platelet activation using anti-GMP-140 monoclonal antibody / L. Undar, N. Akkoc, M.N. Alakavuklar // Chronobiol. Int. — 1999. — Vol. 16(3) — P. 335−342.
- Ushiyama S. Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin / S. Ushiyama, T. Laue, K. Moore // J. Biol. Chem. — 1993. — Vol. 268. — P. 15 229.
- Vaitkus P.T. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty / P.T. Vaitkus, M.W. Watkins, W.T. Witmer // Coron. Artery Dis. — 1995. — Vol. 6. — P. 587 592.
- Wallen N.H. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls / N.H. Wallen, C. Held, N. Rehnqvist // Eur. Heart J. — 1997. — Vol. 18. — P. 807−815.
- Wang J.S. Different effects of strenuous exercise and moderate exercise on platelet function in men / J.S.Wang, C.J. Jen, H.C. Kung // Circulation. — 1994. —1. Vol. 90. —P. 2877−2885.
- Wencel-Drake J.D. Internalization of bound fibrinogen modulates platelet aggregation / J.D. Wencel-Drake, C. Boudignon-Proudhon, M.G. Dieter // Blood. — 1996. — Vol. 87. —P. 602.
- Wikstrand J. Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study / J. Wikstrand, I. Warnold, J. Tuomilehto // Hypertension. — 1991. — Vol. 17(4). — P. 579−588.
- Winokur R. Mechanism of shape change in chilled human platelets / R. Winokur, J. Hartwig // Blood. — 1995. — Vol. 85. — P. 1796.
- Xie X.M. Effect of losartan and amilodipine on the platelet activation and renal function in patients with mild and moderate hypertension / X.M. Xie, G.L. Yu, P. Zhou // Hunan Yi Ke Da Xue Xue Bao. — 2002. — Vol. 28−27(2). — P. 130−132.
- Yoshimoto H. Exogenous nitric oxide inhibits platelet activation in whole blood / H. Yoshimoto, A. Suehiro, E. Kakishita // J. Cardiovasc. Pharmacol. — 1999. — Vol. 33(1). —P. 109−115.
- Zee R.Y. Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis / R.Y. Zee, N.R. Cook, S. Cheng // Hum. Mol. Genet. — 2004. — Vol. 13(4). — P. 389−396.
- Zhao L. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro / L. Zhao, P. Bath, S. Heptinstall // Br. J. Pharmacol. — 2001. — Vol. 134(2). — P. 353−358.